Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Maturational stage-dependent thymocyte responses to TCR engagement.

Kattman SJ, Lukin KR, Oh JZ, Berg RE, Staerz UD.

Eur J Immunol. 2005 Jul;35(7):2051-60.

2.

A physiological ligand of positive selection is recognized as a weak agonist.

Berg RE, Irion S, Kattman S, Princiotta MF, Staerz UD.

J Immunol. 2000 Oct 15;165(8):4209-16.

3.

A physiological ligand of positive selection is seen with high specificity.

Irion S, Berg RE, Staerz UD.

J Immunol. 2000 May 1;164(9):4601-6.

4.

Induction of specific immune tolerance with hybrid antibodies.

Staerz UD, Lee DS, Qi Y.

Immunol Today. 2000 Apr;21(4):172-6. Review. No abstract available.

PMID:
10740237
5.

Liposome encapsulated aurothiomalate reduces collagen-induced arthritis in DBA/1J mice.

Konigsberg PJ, Debrick JE, Pawlowski TJ, Staerz UD.

Biochim Biophys Acta. 1999 Sep 21;1421(1):149-62.

6.

Treatment of an autoimmune disease with "classical" T cell veto: a proposal.

Staerz UD, Qi Y.

J Clin Immunol. 1999 Jul;19(4):195-202. Review.

PMID:
10471973
7.

Positive selection of an H2-M3 restricted T cell receptor.

Berg RE, Princiotta MF, Irion S, Moticka JA, Dahl KR, Staerz UD.

Immunity. 1999 Jul;11(1):33-43.

8.

H2-M3 restricted presentation of a Listeria-derived leader peptide.

Princiotta MF, Lenz LL, Bevan MJ, Staerz UD.

J Exp Med. 1998 May 18;187(10):1711-9.

9.

Specific inhibition of CD4+ T lymphocytes by a hybrid antibody.

Qi Y, Staerz UD.

Nat Biotechnol. 1998 Mar;16(3):271-5.

PMID:
9528008
10.

Hybrid antibody mediated veto of cytotoxic T lymphocyte responses.

Qi Y, Berg R, Singleton MA, Debrick JE, Staerz UD.

J Exp Med. 1996 May 1;183(5):1973-80.

11.

Permissive recognition during positive selection.

Pawlowski TJ, Singleton MD, Loh DY, Berg R, Staerz UD.

Eur J Immunol. 1996 Apr;26(4):851-7.

PMID:
8625978
12.

T cell receptor V beta 8.2 gene germ-line transcription: an early event of lymphocyte differentiation.

Candéias S, Hardy RR, Li YS, Staerz UD.

Eur J Immunol. 1994 Dec;24(12):3073-81.

PMID:
7805736
13.

How are alpha beta T cells positively selected in the thymus?

Pawlowski TJ, Staerz UD.

Behring Inst Mitt. 1994 Jul;(94):94-103. Review.

PMID:
7998918
14.

Thymic education--T cells do it for themselves.

Pawlowski TJ, Staerz UD.

Immunol Today. 1994 May;15(5):205-9. Review.

PMID:
8024679
15.

Positive selection of T lymphocytes on fibroblasts.

Pawlowski T, Elliott JD, Loh DY, Staerz UD.

Nature. 1993 Aug 12;364(6438):642-5.

PMID:
8350923
16.

Concepts of antibody-mediated cancer therapy.

Kummer U, Staerz UD.

Cancer Invest. 1993;11(2):174-84. Review. No abstract available.

PMID:
8462018
17.

[Monoclonal hybrid antibodies. New perspectives for basic research and tumor therapy].

Zepp F, Staerz UD.

Monatsschr Kinderheilkd. 1992 Oct;140(10):745-52. Review. German.

PMID:
1435794
18.

Macrophages as accessory cells for class I MHC-restricted immune responses.

Debrick JE, Campbell PA, Staerz UD.

J Immunol. 1991 Nov 1;147(9):2846-51.

PMID:
1833459
19.

Recruitment of alloreactive cytotoxic T lymphocytes by an antigenic peptide.

Staerz UD, Zepp F, Schmid R, Hill M, Rothbard J.

Eur J Immunol. 1989 Dec;19(12):2191-6.

PMID:
2481586
20.

Redirecting the cellular immune response.

Staerz UD, Bevan MJ.

Int Rev Immunol. 1989 May;4(2):159-73. Review.

PMID:
2485840
21.

Thymic selection process induced by hybrid antibodies.

Zepp F, Staerz UD.

Nature. 1988 Dec 1;336(6198):473-5.

PMID:
3057386
22.

Tolerance in T-cell-receptor transgenic mice involves deletion of nonmature CD4+8+ thymocytes.

Kisielow P, Blüthmann H, Staerz UD, Steinmetz M, von Boehmer H.

Nature. 1988 Jun 23;333(6175):742-6.

PMID:
3260350
23.

Cytotoxic T lymphocytes against a soluble protein.

Staerz UD, Karasuyama H, Garner AM.

Nature. 1987 Oct 1-7;329(6138):449-51.

PMID:
2443853
24.

Lysis of nonnucleated red blood cells by cytotoxic T lymphocytes.

Lanzavecchia A, Staerz UD.

Eur J Immunol. 1987 Jul;17(7):1073-4.

PMID:
3111858
25.

A new T helper cell specificity within the pigeon cytochrome c determinant 95-104.

Carbone FR, Staerz UD, Paterson Y.

Eur J Immunol. 1987 Jun;17(6):897-9.

PMID:
2439353
26.

Hybrid antibody-mediated lysis of virus-infected cells.

Staerz UD, Yewdell JW, Bevan MJ.

Eur J Immunol. 1987 Apr;17(4):571-4.

PMID:
3494618
27.

Use of anti-receptor antibodies to focus T-cell activity.

Staerz UD, Bevan MI.

Immunol Today. 1986 Jul-Aug;7(7-8):241-5. doi: 10.1016/0167-5699(86)90112-X.

PMID:
25290407
28.
30.

Targeting cells for attack by cytotoxic T lymphocytes using heteroconjugates of monoclonal antibodies.

Staerz UD, Bevan MJ.

Symp Fundam Cancer Res. 1986;38:31-4. No abstract available.

PMID:
3489261
31.

Cytotoxic T lymphocyte-mediated lysis via the Fc receptor of target cells.

Staerz UD, Bevan MJ.

Eur J Immunol. 1985 Dec;15(12):1172-7.

PMID:
2935404
32.

Selective activation of Lyt 2+ precursor T cells by ligation of the antigen receptor.

Crispe IN, Bevan MJ, Staerz UD.

Nature. 1985 Oct 17-23;317(6038):627-9.

PMID:
3877242
33.

Characterization of a murine monoclonal antibody specific for an allotypic determinant on T cell antigen receptor.

Staerz UD, Rammensee HG, Benedetto JD, Bevan MJ.

J Immunol. 1985 Jun;134(6):3994-4000.

PMID:
2580901
34.

Hybrid antibodies can target sites for attack by T cells.

Staerz UD, Kanagawa O, Bevan MJ.

Nature. 1985 Apr 18-24;314(6012):628-31.

PMID:
2859527
35.

Studies on the mechanism of suppression of primary cytotoxic responses by cloned cytotoxic T lymphocytes.

Fink PJ, Rammensee HG, Benedetto JD, Staerz UD, Lefrancois L, Bevan MJ.

J Immunol. 1984 Oct;133(4):1769-74.

PMID:
6236258
36.

Monoclonal antibodies specific for a murine cytotoxic T-lymphocyte clone.

Staerz UD, Pasternack MS, Klein JR, Benedetto JD, Bevan MJ.

Proc Natl Acad Sci U S A. 1984 Mar;81(6):1799-803.

Supplemental Content

Loading ...
Support Center